Kallyope Inc..'s early discovery research into the gut-brain axis is beginning to mature, with the company's focus now on translating that research into the development of potential drug candidates.
"I'm hopeful that no later than next year we will be in preclinical development and moving towards the clinic," CEO...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?